ochratoxin a has been researched along with caffeic acid phenethyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Al-Anati, L; Katz, N; Petzinger, E | 1 |
2 other study(ies) available for ochratoxin a and caffeic acid phenethyl ester
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Interference of arachidonic acid and its metabolites with TNF-alpha release by ochratoxin A from rat liver.
Topics: Animals; Arachidonic Acid; Aristolochic Acids; Caffeic Acids; Dose-Response Relationship, Drug; In Vitro Techniques; Indomethacin; Liver; Male; NF-kappa B; Ochratoxins; Phenylethyl Alcohol; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha | 2005 |